Literature DB >> 11704676

Identification, characterization, and crystal structure of Bacillus subtilis nicotinic acid mononucleotide adenylyltransferase.

Andrea M Olland1, Kathryn W Underwood, Robert M Czerwinski, Mei-Chu Lo, Ann Aulabaugh, Joel Bard, Mark L Stahl, William S Somers, Francis X Sullivan, Rajiv Chopra.   

Abstract

The nadD gene, encoding the enzyme nicotinic acid mononucleotide (NaMN) adenylyltransferase (AT), is essential for the synthesis of NAD and subsequent viability of the cell. The nadD gene in Bacillus subtilis (yqeJ) was identified by sequence homology with other bacterial nadD genes and by biochemical characterization of the gene product. NaMN AT catalyzes the reversible adenylation of both NaMN and the nicotinamide mononucleotide (NMN) but shows specificity for the nicotinate. In contrast to other known NMN ATs, biophysical characterizations reveal it to be a dimer. The NaMN AT crystal structure was determined for both the apo enzyme and product-bound form, to 2.1 and 3.2 A, respectively. The structures reveal a "functional" dimer conserved in both crystal forms and a monomer fold common to members of the nucleotidyl-transferase alpha/beta phosphodiesterase superfamily. A structural comparison with family members suggests a new conserved motif (SXXXX(R/K)) at the N terminus of an alpha-helix, which is not part of the shared fold. Interactions of the nicotinic acid with backbone atoms indicate the structural basis for specificity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11704676     DOI: 10.1074/jbc.M109670200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  A genetic strategy to identify targets for the development of drugs that prevent bacterial persistence.

Authors:  Jee-Hyun Kim; Kathryn M O'Brien; Ritu Sharma; Helena I M Boshoff; German Rehren; Sumit Chakraborty; Joshua B Wallach; Mercedes Monteleone; Daniel J Wilson; Courtney C Aldrich; Clifton E Barry; Kyu Y Rhee; Sabine Ehrt; Dirk Schnappinger
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

2.  Mycobacterial nicotinate mononucleotide adenylyltransferase: structure, mechanism, and implications for drug discovery.

Authors:  Irina A Rodionova; Harmon J Zuccola; Leonardo Sorci; Alexander E Aleshin; Marat D Kazanov; Chen-Ting Ma; Eduard Sergienko; Eric J Rubin; Christopher P Locher; Andrei L Osterman
Journal:  J Biol Chem       Date:  2015-01-28       Impact factor: 5.157

3.  Complexes of bacterial nicotinate mononucleotide adenylyltransferase with inhibitors: implication for structure-based drug design and improvement.

Authors:  Nian Huang; Rohit Kolhatkar; Yvonne Eyobo; Leonardo Sorci; Irina Rodionova; Andrei L Osterman; Alexander D Mackerell; Hong Zhang
Journal:  J Med Chem       Date:  2010-07-22       Impact factor: 7.446

4.  Characterization of human brain nicotinamide 5'-mononucleotide adenylyltransferase-2 and expression in human pancreas.

Authors:  Joel A Yalowitz; Suhong Xiao; Mangatt P Biju; Aśok C Antony; Oscar W Cummings; Mark A Deeg; Hiremagalur N Jayaram
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

5.  Hyperthermophilic Archaeon Thermococcus kodakarensis Utilizes a Four-Step Pathway for NAD+ Salvage through Nicotinamide Deamination.

Authors:  Shin-Ichi Hachisuka; Takaaki Sato; Haruyuki Atomi
Journal:  J Bacteriol       Date:  2018-05-09       Impact factor: 3.490

Review 6.  Nicotinamide/nicotinic acid mononucleotide adenylyltransferase, new insights into an ancient enzyme.

Authors:  Rong Grace Zhai; Menico Rizzi; Silvia Garavaglia
Journal:  Cell Mol Life Sci       Date:  2009-05-16       Impact factor: 9.261

7.  From genetic footprinting to antimicrobial drug targets: examples in cofactor biosynthetic pathways.

Authors:  Svetlana Y Gerdes; Michael D Scholle; Mark D'Souza; Axel Bernal; Mark V Baev; Michael Farrell; Oleg V Kurnasov; Matthew D Daugherty; Faika Mseeh; Boris M Polanuyer; John W Campbell; Shubha Anantha; Konstantin Y Shatalin; Shamim A K Chowdhury; Michael Y Fonstein; Andrei L Osterman
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

8.  Bifunctional NMN adenylyltransferase/ADP-ribose pyrophosphatase: structure and function in bacterial NAD metabolism.

Authors:  Nian Huang; Leonardo Sorci; Xuejun Zhang; Chad A Brautigam; Xiaoqing Li; Nadia Raffaelli; Giulio Magni; Nick V Grishin; Andrei L Osterman; Hong Zhang
Journal:  Structure       Date:  2008-02       Impact factor: 5.006

9.  Targeting NAD biosynthesis in bacterial pathogens: Structure-based development of inhibitors of nicotinate mononucleotide adenylyltransferase NadD.

Authors:  Leonardo Sorci; Yongping Pan; Yvonne Eyobo; Irina Rodionova; Nian Huang; Oleg Kurnasov; Shijun Zhong; Alexander D MacKerell; Hong Zhang; Andrei L Osterman
Journal:  Chem Biol       Date:  2009-08-28

10.  Quinolinate salvage and insights for targeting NAD biosynthesis in group A streptococci.

Authors:  Leonardo Sorci; Ian K Blaby; Irina A Rodionova; Jessica De Ingeniis; Sergey Tkachenko; Valérie de Crécy-Lagard; Andrei L Osterman
Journal:  J Bacteriol       Date:  2012-11-30       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.